Cinqair (reslizumab) has been approved by the U.S.Food and Drug Administration to treat serious asthma among adults 18 and older.
25 Oct '21 14:25PM
21 Oct '21 20:44PM
21 Oct '21 10:44AM
15 Oct '21 15:18PM
04 Oct '21 10:20AM
04 Oct '21 09:56AM
01 Oct '21 16:31PM